Literature DB >> 21633357

Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney.

Ye Zhang1, Chunjiang Fu, Laureano D Asico, Van Anthony M Villar, Hongmei Ren, Duofen He, Zhen Wang, Jian Yang, Pedro A Jose, Chunyu Zeng.   

Abstract

The D(3) dopamine receptor is the major D(2)-like receptor that regulates sodium transport in the renal proximal tubule (RPT) and helps maintain blood pressure in the normal range. In Wistar-Kyoto (WKY) rats chronically fed high-salt diet, the intrarenal arterial infusion of a D(3) receptor agonist, PD128907, increased absolute and fractional sodium excretion. We have reported that Gα(12) and Gα(13), which participate in the signal transduction of the D(5) receptor, are expressed in RPTs. As the D(3) receptor is also expressed in RPTs, we hypothesized that it may also interact with Gα(12)/Gα(13) in RPTs from WKY rats. There were co-localization and co-immunoprecipitation of D(3) receptor and Gα(12)/Gα(13) in renal brush border membranes (BBMs) and RPT cells. The intrarenal infusion of PD128907 (1 μg kg(-1) min(-1)) that increased sodium excretion also increased the co-immunoprecipitations of D(3)/Gα(12) and D(3)/Gα(13) in renal BBMs; their co-immunoprecipitation was confirmed in RPT cells. As Gα(12) and Gα(13) increase sodium pump and transporter activity (for example, Na(+)-K(+)-ATPase, NHE3), an increased association of D(3) receptors with Gα(12)/Gα(13) receptors after D(3) receptor activation may be a mechanism to prevent Gα(12)/Gα(13)-mediated stimulation of sodium transport (and thus enhance natriuresis). We conclude that a D(3) receptor interaction with Gα(12)/Gα(13) that increases sodium excretion may have a role in the regulation of blood pressure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633357      PMCID: PMC3987779          DOI: 10.1038/hr.2011.70

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  29 in total

Review 1.  Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.

Authors:  U Gether
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

2.  SHP-1 expression in avian mixed neural/glial cultures.

Authors:  Jeffrey D Sorbel; Diane M Brooks; Diana I Lurie
Journal:  J Neurosci Res       Date:  2002-06-15       Impact factor: 4.164

3.  Effects of long-term ouabain treatment on blood pressure, sodium excretion, and renal dopamine D(1) receptor levels in rats.

Authors:  Yurong Zhang; Zuyi Yuan; Heng Ge; Yanping Ren
Journal:  J Comp Physiol B       Date:  2009-07-22       Impact factor: 2.200

4.  Galpha12- and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron.

Authors:  Shaopeng Zheng; Peiying Yu; Chunyu Zeng; Zheng Wang; Zhiwei Yang; Peter M Andrews; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2003-02-24       Impact factor: 10.190

5.  Impaired renal D(1)-like and D(2)-like dopamine receptor interaction in the spontaneously hypertensive rat.

Authors:  C A Ladines; C Zeng; L D Asico; X Sun; F Pocchiari; C Semeraro; J Pisegna; S Wank; I Yamaguchi; G M Eisner; P A Jose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-10       Impact factor: 3.619

Review 6.  Regulation of G protein-initiated signal transduction in yeast: paradigms and principles.

Authors:  H G Dohlman; J W Thorner
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

7.  Activation of MAPKs in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats.

Authors:  A Parenti; X L Cui; U Hopfer; M Ziche; J G Douglas
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

8.  Dopamine D(3) receptors and salt-dependent hypertension.

Authors:  Gerd Luippold; Claudia Zimmermann; Matthias Mai; Doris Kloor; Dorothea Starck; Gerhard Gross; Bernd Mühlbauer
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

Review 9.  Regulation of renin: new evidence from cultured cells and genetically modified mice.

Authors:  M Bader; D Ganten
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

Review 10.  Renal dopamine receptors and hypertension.

Authors:  Tahir Hussain; Mustafa F Lokhandwala
Journal:  Exp Biol Med (Maywood)       Date:  2003-02
View more
  6 in total

1.  Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12.

Authors:  Zhen Wang; Weiwei Guan; Yu Han; Hongmei Ren; Xiaofeng Tang; Hui Zhang; Yukai Liu; Jinjuan Fu; Duofen He; Laureano D Asico; Pedro A Jose; Lin Zhou; Liyong Chen; Chunyu Zeng
Journal:  Transplantation       Date:  2015-11       Impact factor: 4.939

2.  Long-Term Exposure of Fine Particulate Matter Causes Hypertension by Impaired Renal D1 Receptor-Mediated Sodium Excretion via Upregulation of G-Protein-Coupled Receptor Kinase Type 4 Expression in Sprague-Dawley Rats.

Authors:  Xi Lu; Zhengmeng Ye; Shuo Zheng; Hongmei Ren; Jing Zeng; Xinquan Wang; Pedro A Jose; Ken Chen; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2018-01-07       Impact factor: 5.501

Review 3.  Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications.

Authors:  Alejandro Olivares-Hernández; Luis Figuero-Pérez; Juan Jesus Cruz-Hernandez; Rogelio González Sarmiento; Ricardo Usategui-Martin; José Pablo Miramontes-González
Journal:  Biomolecules       Date:  2021-02-10

Review 4.  The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension.

Authors:  Waleed N Qaddumi; Pedro A Jose
Journal:  Biomedicines       Date:  2021-02-01

Review 5.  Lipid Rafts and Dopamine Receptor Signaling.

Authors:  Victor J Martinez; Laureano D Asico; Pedro A Jose; Andrew C Tiu
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

6.  Synergistic Effect of Uroguanylin and D1 Dopamine Receptors on Sodium Excretion in Hypertension.

Authors:  Cindy Zeng; Tianyang Xia; Shuo Zheng; Lijia Liang; Yue Chen
Journal:  J Am Heart Assoc       Date:  2022-03-01       Impact factor: 6.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.